BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 31172381)

  • 1. Use of TCR α
    Brettig T; Smart J; Choo S; Mechinaud F; Mitchell R; Raj TS; Cole T
    J Clin Immunol; 2019 Jul; 39(5):505-511. PubMed ID: 31172381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Center Experience of Unrelated and Haploidentical Stem Cell Transplantation with TCRαβ and CD19 Depletion in Children with Primary Immunodeficiency Syndromes.
    Balashov D; Shcherbina A; Maschan M; Trakhtman P; Skvortsova Y; Shelikhova L; Laberko A; Livshits A; Novichkova G; Maschan A
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1955-62. PubMed ID: 26187864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell receptor αβ
    Shah RM; Elfeky R; Nademi Z; Qasim W; Amrolia P; Chiesa R; Rao K; Lucchini G; Silva JMF; Worth A; Barge D; Ryan D; Conn J; Cant AJ; Skinner R; Abd Hamid IJ; Flood T; Abinun M; Hambleton S; Gennery AR; Veys P; Slatter M
    J Allergy Clin Immunol; 2018 Apr; 141(4):1417-1426.e1. PubMed ID: 28780238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Modulation Properties of Zoledronic Acid on TcRγδ T-Lymphocytes After TcRαβ/CD19-Depleted Haploidentical Stem Cell Transplantation: An analysis on 46 Pediatric Patients Affected by Acute Leukemia.
    Merli P; Algeri M; Galaverna F; Milano GM; Bertaina V; Biagini S; Girolami E; Palumbo G; Sinibaldi M; Becilli M; Leone G; Boccieri E; Grapulin L; Gaspari S; Airoldi I; Strocchio L; Pagliara D; Locatelli F
    Front Immunol; 2020; 11():699. PubMed ID: 32477328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TCR α
    Mitchell R; Cole T; Shaw PJ; Mechinaud F; O'Brien T; Fraser C
    Pediatr Transplant; 2019 Sep; 23(6):e13517. PubMed ID: 31271477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD3
    Ramanathan S; Lum SH; Nademi Z; Carruthers K; Watson H; Flood T; Owens S; Williams E; Hambleton S; Gennery AR; Slatter M
    Transplant Cell Ther; 2023 Aug; 29(8):513.e1-513.e9. PubMed ID: 37279857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for and the Clinical Impact of Cytomegalovirus and Epstein-Barr Virus Infections in Pediatric Recipients of TCR-α/β- and CD19-Depleted Grafts.
    Laberko A; Bogoyavlenskaya A; Shelikhova L; Shekhovtsova Z; Balashov D; Voronin K; Kurnikova E; Boyakova E; Raykina E; Brilliantova V; Pirumova V; Novichkova G; Maschan A; Maschan M
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):483-490. PubMed ID: 28039080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-transplantation of mesenchymal stromal cell and haploidentical hematopoietic stem cell with TCR αβ depletion in children with primary immunodeficiency syndromes.
    Atay D; Akcay A; Akinci B; Yenigurbuz FD; Ovali E; Ozturk G
    Pediatr Transplant; 2021 Dec; 25(8):e14120. PubMed ID: 34409718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haploidentical Stem Cell Transplantation After TCR-αβ
    Giardino S; Bagnasco F; Falco M; Miano M; Pierri F; Risso M; Terranova P; Di Martino D; Massaccesi E; Ricci M; Chianucci B; Dell'Orso G; Sabatini F; Podestà M; Lanino E; Faraci M
    Transplant Cell Ther; 2022 Jul; 28(7):394.e1-394.e9. PubMed ID: 35405368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Primary Immunodeficiencies and Inherited Disorders in Children.
    Neven B; Diana JS; Castelle M; Magnani A; Rosain J; Touzot F; Moreira B; Fremond ML; Briand C; Bendavid M; Levy R; Morelle G; Vincent M; Magrin E; Bourget P; Chatenoud L; Picard C; Fischer A; Moshous D; Blanche S
    Biol Blood Marrow Transplant; 2019 Jul; 25(7):1363-1373. PubMed ID: 30876929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Reconstitution Following TCRαβ/CD19-Depleted Hematopoietic Cell Transplantation for Hematologic Malignancy in Pediatric Patients.
    Arnold DE; MacMath D; Seif AE; Heimall JR; Wang Y; Monos D; Grupp SA; Bunin NJ
    Transplant Cell Ther; 2021 Feb; 27(2):169.e1-169.e9. PubMed ID: 33830028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel treatment of severe combined immunodeficiency utilizing ex-vivo T-cell depleted haploidentical hematopoietic stem cell transplantation and CD45RA+ depleted donor lymphocyte infusions.
    Brodszki N; Turkiewicz D; Toporski J; Truedsson L; Dykes J
    Orphanet J Rare Dis; 2016 Jan; 11():5. PubMed ID: 26768987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mismatched related vs matched unrelated donors in TCRαβ/CD19-depleted HSCT for primary immunodeficiencies.
    Laberko A; Sultanova E; Gutovskaya E; Shipitsina I; Shelikhova L; Kurnikova E; Muzalevskii Y; Kazachenok A; Pershin D; Voronin K; Shcherbina A; Maschan M; Maschan A; Balashov D
    Blood; 2019 Nov; 134(20):1755-1763. PubMed ID: 31558465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New graft manipulation strategies improve the outcome of mismatched stem cell transplantation in children with primary immunodeficiencies.
    Elfeky R; Shah RM; Unni MNM; Ottaviano G; Rao K; Chiesa R; Amrolia P; Worth A; Flood T; Abinun M; Hambleton S; Cant AJ; Gilmour K; Adams S; Ahsan G; Barge D; Gennery AR; Qasim W; Slatter M; Veys P
    J Allergy Clin Immunol; 2019 Jul; 144(1):280-293. PubMed ID: 30731121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative donor: αß/CD19 T-cell-depleted haploidentical hematopoietic stem cell transplantation for sickle cell disease.
    Foell J; Kleinschmidt K; Jakob M; Troeger A; Corbacioglu S
    Hematol Oncol Stem Cell Ther; 2020 Jun; 13(2):98-105. PubMed ID: 32202248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter Outcome of Hematopoietic Stem Cell Transplantation for Primary Immune Deficiency Disorders in India.
    Raj R; Aboobacker FN; Yadav SP; Uppuluri R; Bhat S; Choudhry D; Dua V; Kharya G; Rastogi N; Sachdev M; Khandelwal V; Swaminathan V; Bakane A; Ramakrishnan B; George B
    Front Immunol; 2020; 11():606930. PubMed ID: 33488609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the cost of preparing matched unrelated donor and TCR α
    van Sambeek B; Flattery M; Mitchell R; De Abreu Lourenco R
    Pediatr Transplant; 2018 Nov; 22(7):e13279. PubMed ID: 30091256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haploidentical HSCT for hemoglobinopathies: improved outcomes with TCRαβ
    Gaziev J; Isgrò A; Sodani P; Paciaroni K; De Angelis G; Marziali M; Ribersani M; Alfieri C; Lanti A; Galluccio T; Adorno G; Andreani M
    Blood Adv; 2018 Feb; 2(3):263-270. PubMed ID: 29431621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Conditioning Regimen with Plerixafor Is Safe and Improves the Outcome of TCRαβ
    Balashov D; Laberko A; Shcherbina A; Trakhtman P; Abramov D; Gutovskaya E; Kozlovskaya S; Shelikhova L; Novichkova G; Maschan M; Rumiantsev A; Maschan A
    Biol Blood Marrow Transplant; 2018 Jul; 24(7):1432-1440. PubMed ID: 29550630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matched versus Haploidentical Hematopoietic Stem Cell Transplantation as Treatment Options for Primary Immunodeficiencies in Children.
    Holzer U; Döring M; Eichholz T; Ebinger M; Queudeville M; Turkiewicz D; Schwarz K; Handgretinger R; Lang P; Toporski J
    Transplant Cell Ther; 2021 Jan; 27(1):71.e1-71.e12. PubMed ID: 32966882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.